Increased Clonal Hematopoiesis in Long-term Survivors of Pediatric Hematopoietic Cell Transplantation.

Abstract

COI Statement

D.S. Neuberg reports other support from Madrigal Pharmaceuticals outside the submitted work. M.E. Belderbos reports grants from Nederlandse Organisatie voor Wetenschappelijk Onderzoek, the European Hematology Association, DKMS Foundation, and Stichting Kinderen Kankervrij during the conduct of the study. No disclosures were reported by the other authors.

References:

• Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman P V., Mar BG, et al. . Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 2014;371:2488–98.
• Genovese G, Kähler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, et al. . Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 2014;371:2477–87.
• Zink F, Stacey SN, Norddahl GL, Frigge ML, Magnusson OT, Jonsdottir I, et al. . Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood 2017;130:742–52.
• van Zeventer IA, de Graaf AO, Salzbrunn JB, Nolte IM, Kamphuis P, Dinmohamed A, et al. . Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population. Cancer Cell 2023;41:1017–31.e4.
• Fabre MA, de Almeida JG, Fiorillo E, Mitchell E, Damaskou A, Rak J, et al. . The longitudinal dynamics and natural history of clonal haematopoiesis. Nature 2022;606:335–42.